Y-mAbs Therapeutics (YMAB) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

YMAB is expected to report earnings to fall 31.95% to -14 cents per share on November 12

Y-mAbs Therapeutics YMAB Stock Earnings Reports

Q3'24

Est.

$-0.14

Q2'24

Missed

by $0.09

Q1'24

Missed

by $0.01

Q4'23

Beat

by $0.18

Q3'23

Beat

by $0.01

The last earnings report on August 12 showed earnings per share of -20 cents, missing the estimate of -11 cents. With 176.01K shares outstanding, the current market capitalization sits at 577.18M.

View a ticker or compare two or three

Compare

YMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For YMAB
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for YMAB (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

230 Park Avenue

Phone

+1 646 885-8505

Employees

100

Web

https://www.ymabs.com